- Home
- MRVI vs PRAA Comparison
MRVI vs PRAA Comparison
Compare MRVI & PRAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- PRAA
- Stock Information
- Founded
- MRVI 2020
- PRAA 1996
- Country
- MRVI United States
- PRAA United States
- Employees
- MRVI N/A
- PRAA N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- PRAA Finance: Consumer Services
- Sector
- MRVI Health Care
- PRAA Finance
- Exchange
- MRVI Nasdaq
- PRAA Nasdaq
- Market Cap
- MRVI 795.7M
- PRAA 834.7M
- IPO Year
- MRVI 2020
- PRAA N/A
- Fundamental
- Price
- MRVI $4.11
- PRAA $22.57
- Analyst Decision
- MRVI Buy
- PRAA Strong Buy
- Analyst Count
- MRVI 10
- PRAA 2
- Target Price
- MRVI $10.28
- PRAA $32.00
- AVG Volume (30 Days)
- MRVI 2.4M
- PRAA 218.4K
- Earning Date
- MRVI 02-25-2025
- PRAA 02-19-2025
- Dividend Yield
- MRVI N/A
- PRAA N/A
- EPS Growth
- MRVI N/A
- PRAA N/A
- EPS
- MRVI N/A
- PRAA 1.79
- Revenue
- MRVI $276,920,000.00
- PRAA $1,114,524,000.00
- Revenue This Year
- MRVI N/A
- PRAA $39.43
- Revenue Next Year
- MRVI $1.93
- PRAA $6.61
- P/E Ratio
- MRVI N/A
- PRAA $12.61
- Revenue Growth
- MRVI N/A
- PRAA 38.87
- 52 Week Low
- MRVI $3.93
- PRAA $18.64
- 52 Week High
- MRVI $11.56
- PRAA $28.64
- Technical
- Relative Strength Index (RSI)
- MRVI 35.37
- PRAA 50.71
- Support Level
- MRVI $4.05
- PRAA $21.62
- Resistance Level
- MRVI $4.40
- PRAA $23.97
- Average True Range (ATR)
- MRVI 0.31
- PRAA 0.81
- MACD
- MRVI -0.05
- PRAA -0.07
- Stochastic Oscillator
- MRVI 15.38
- PRAA 50.70
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About PRAA PRA Group Inc.
PRA Group Inc is a leader in acquiring and collecting nonperforming loans. The company returns capital to banks and other creditors to help expand financial services for consumers in the Americas, Europe, and Australia. It is also engaged in providing fee-based services on class action claims recoveries in the United States. The company's portfolio segments include; Core, which is engaged in purchasing and collecting nonperforming loans, which the originators have not chosen not to pursue, and the Insolvency segment which is engaged in purchasing and collecting nonperforming loans where the customer is involved in a bankruptcy proceeding.